Cargando…

Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V

INTRODUCTION: Economic evaluations of lifestyle interventions for people with mental illness are needed to inform policy makers and managers about implementing such interventions and corresponding reforms in routine mental healthcare. OBJECTIVES: We aimed to evaluate changes in healthcare costs 18 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Deenik, J., Van Lieshout, C., Van Driel, H., Frederix, G., Hendriksen, I., Van Harten, P., Tenback, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566607/
http://dx.doi.org/10.1192/j.eurpsy.2022.872
_version_ 1784809191466074112
author Deenik, J.
Van Lieshout, C.
Van Driel, H.
Frederix, G.
Hendriksen, I.
Van Harten, P.
Tenback, D.
author_facet Deenik, J.
Van Lieshout, C.
Van Driel, H.
Frederix, G.
Hendriksen, I.
Van Harten, P.
Tenback, D.
author_sort Deenik, J.
collection PubMed
description INTRODUCTION: Economic evaluations of lifestyle interventions for people with mental illness are needed to inform policy makers and managers about implementing such interventions and corresponding reforms in routine mental healthcare. OBJECTIVES: We aimed to evaluate changes in healthcare costs 18 months after the implementation of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness (MULTI) versus treatment as usual (TAU). METHODS: In a cohort study (n=114; 65 MULTI, 49 TAU), we retrospectively retrieved cost data in Euros on all patient sessions, ward stay, medication use, and hospital referrals in the quarter year at the start of MULTI (Q1 2014) and after its evaluation (Q3 2015). We used linear regression analyses correcting for baseline values and differences between groups, calculated quality-adjusted life years (QALY) and deterministic incremental cost-effectiveness ratios, and performed probabilistic sensitivity analyses. RESULTS: Adjusted regression showed reduced total costs per patient per quarter year in favor of MULTI (B=-736.30, 95%CI: -2145.2–672.6). Corresponding probabilistic sensitivity analysis accounting for uncertainty surrounding the parameters showed MULTI was dominant over TAU with a saving in total costs of €417.48 (95%-CI: -2,873.2–2,042.1) against 0.06 improvement in QALY (95%-CI: -0.08–0.20). Costs saving estimates were statistically non-significant showing wide confidence intervals. CONCLUSIONS: Regardless of cost savings, MULTI did not increase healthcare costs while improving QALY and additional previously observed health outcomes. This indicates that starting lifestyle interventions does not need to be hampered by costs. Potential societal and economic value may justify investment to support implementation and maintenance. Further research is needed to study this hypothesis. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9566607
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95666072022-10-17 Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V Deenik, J. Van Lieshout, C. Van Driel, H. Frederix, G. Hendriksen, I. Van Harten, P. Tenback, D. Eur Psychiatry Abstract INTRODUCTION: Economic evaluations of lifestyle interventions for people with mental illness are needed to inform policy makers and managers about implementing such interventions and corresponding reforms in routine mental healthcare. OBJECTIVES: We aimed to evaluate changes in healthcare costs 18 months after the implementation of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness (MULTI) versus treatment as usual (TAU). METHODS: In a cohort study (n=114; 65 MULTI, 49 TAU), we retrospectively retrieved cost data in Euros on all patient sessions, ward stay, medication use, and hospital referrals in the quarter year at the start of MULTI (Q1 2014) and after its evaluation (Q3 2015). We used linear regression analyses correcting for baseline values and differences between groups, calculated quality-adjusted life years (QALY) and deterministic incremental cost-effectiveness ratios, and performed probabilistic sensitivity analyses. RESULTS: Adjusted regression showed reduced total costs per patient per quarter year in favor of MULTI (B=-736.30, 95%CI: -2145.2–672.6). Corresponding probabilistic sensitivity analysis accounting for uncertainty surrounding the parameters showed MULTI was dominant over TAU with a saving in total costs of €417.48 (95%-CI: -2,873.2–2,042.1) against 0.06 improvement in QALY (95%-CI: -0.08–0.20). Costs saving estimates were statistically non-significant showing wide confidence intervals. CONCLUSIONS: Regardless of cost savings, MULTI did not increase healthcare costs while improving QALY and additional previously observed health outcomes. This indicates that starting lifestyle interventions does not need to be hampered by costs. Potential societal and economic value may justify investment to support implementation and maintenance. Further research is needed to study this hypothesis. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9566607/ http://dx.doi.org/10.1192/j.eurpsy.2022.872 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Deenik, J.
Van Lieshout, C.
Van Driel, H.
Frederix, G.
Hendriksen, I.
Van Harten, P.
Tenback, D.
Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V
title Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V
title_full Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V
title_fullStr Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V
title_full_unstemmed Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V
title_short Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V
title_sort cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the multi study v
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566607/
http://dx.doi.org/10.1192/j.eurpsy.2022.872
work_keys_str_mv AT deenikj costeffectivenessofamultidisciplinarylifestyleenhancingtreatmentforinpatientswithseverementalillnessthemultistudyv
AT vanlieshoutc costeffectivenessofamultidisciplinarylifestyleenhancingtreatmentforinpatientswithseverementalillnessthemultistudyv
AT vandrielh costeffectivenessofamultidisciplinarylifestyleenhancingtreatmentforinpatientswithseverementalillnessthemultistudyv
AT frederixg costeffectivenessofamultidisciplinarylifestyleenhancingtreatmentforinpatientswithseverementalillnessthemultistudyv
AT hendrikseni costeffectivenessofamultidisciplinarylifestyleenhancingtreatmentforinpatientswithseverementalillnessthemultistudyv
AT vanhartenp costeffectivenessofamultidisciplinarylifestyleenhancingtreatmentforinpatientswithseverementalillnessthemultistudyv
AT tenbackd costeffectivenessofamultidisciplinarylifestyleenhancingtreatmentforinpatientswithseverementalillnessthemultistudyv